Novo A/S Archives

Home Novo A/S

Latest Posts

mutabilis novo holdings antibiotic resistance

News and Trends 6 Jan 2020

€5M Investment to Fund French Biotech’s Resistance-Busting Antibiotic

Mutabilis has received a €5M investment from the Danish VC Novo Holdings’ REPAIR Impact Fund to fuel the development of a new class of antibiotics that could kill drug-resistant strains…

January 6, 2020 - 2 minutesmins - By Jonathan Smith

novo nordisk holding impact antimicrobial resistance slides

News and Trends 22 Jan 2019

MinervaX Latest Beneficiary of Novo’s Antimicrobial Resistance Fund

The Novo Holdings REPAIR Impact Fund, launched to fight antimicrobial resistance, has invested €4.4M in the Danish company MinervaX to help fund the phase I trial of a vaccine that…

January 22, 2019 - 2 minutesmins - By Jonathan Smith

novo holdings antibiotic resistance fight 1

News and Trends 28 Feb 2018

Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance

Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing new drugs to overcome antibiotic resistance. Novo Holdings manages the assets of the Novo Nordisk Foundation,…

February 28, 2018 - 3 minutesmins - By Alex Dale

Interview 16 Oct 2017

Meet the Former Banker at the Helm of Denmark’s Healthcare Giant, Novo Holdings

Kasim Kutay has ridden the biotech investment wave. First, he helped build Morgan Stanley’s European healthcare group, then did the same at Moelis & Co and now he heads Novo…

October 16, 2017 - 7 minutesmins - By Evelyn Warner

sofinnova partners industrial biotech fund

News and Trends 15 Mar 2018

French VC Raises the Biggest Green Biotech Fund in the World

Update (15/03/2018): Sofinnova Partners has closed its fund Industrial Biotech I at €125M, making it the largest fund dedicated to driving the transition towards a more sustainable fund. 03/03/2017 Sofinnova…

March 15, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Aug 2015

Dutch Immuno-Oncology company raises Massive Series C Financing round

Sofinnova Ventures and Novo A/S step into one of the biggest European series C financing rounds, which is about €72.8 million. The money goes to the Dutch immuno-oncology company Merus…

August 27, 2015 - 2 minutesmins - By Philip Hemme

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering